| Literature DB >> 7042230 |
Abstract
Niridazole was shown to be an effective chemotherapeutic agent for mice infected intravenously with a niridazole-sensitive strain of Salmonella typhimurium. Death rates as well as bacterial counts per spleen were reduced, even in compromised animals. Histologic examination of spleens proved the reduction of inflammatory reaction due to Salmonella infection. A suppressive effect of niridazole treatment on immunity to challenge infection with S. typhimurium was not found, as demonstrated by infection with a niridazole-resistant strain of S. typhimurium.Entities:
Mesh:
Substances:
Year: 1982 PMID: 7042230 DOI: 10.1159/000238069
Source DB: PubMed Journal: Chemotherapy ISSN: 0009-3157 Impact factor: 2.544